Veeva Systems (VEEV) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $39.60B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Peter Gassner |
| IPO Date | 2013-10-16 | CAGR | 36.78% |
| Employees | 7,928 | Website | www.veeva.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.09% | Total Yield | 0.09% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $34.13B | P/E | 29.26 | Forward P/E | 24.29 | PEG | 3.07 |
| P/S | 132.84 | P/B | 62.2 | P/CF | 268.34 | P/FCF | 860.35 |
| Sales | $3.32B | Sales 1Y | 16.25% | Sales 3Y | 52.52% | Sales 5Y | 112.56% |
| EPS | $8.33 | EPS 1Y | 19.11% | EPS 3Y | 75.31% | EPS 5Y | 121.74% |
| Sales QoQ | 5.62% | EPS QoQ | 8.28% | Sales QoQ Avg | 3.86% | EPS QoQ Avg | 4.09% |
| Gross Margin | 74.95% | Operating Margin | 28.79% | Profit Margin | 28.37% | ROCE | 12.87% |
| ROA | 10% | ROE | 13% | Altman Z Score | 15.27 | Piotroski Score | 5 |
| Current Ratio | 4.74 | Quick Ratio | 4.74 | Cash Ratio | 1.11 | Op. CF Ratio | 0.66 |
| Debt/Equity | 0.01 | Debt/Assets | 0.01 | Lt Debt/Equity | 0.01 | Lt Debt/Cap. | — |
| Intrst Cov. | — | Inventory Turnover | — | Asset Turnover | 0.36 | Receivables Turnover | 5.29 |
| Enterprise Value | $34.13B | P/E Ratio | 29.26 |
| Forward P/E | 24.29 | PEG Ratio | 3.07 |
| P/S Ratio | 132.84 | P/B Ratio | 62.2 |
| P/CF Ratio | 268.34 | P/FCF Ratio | 860.35 |
| EPS | $8.33 | EPS Growth 1Y | 19.11% |
| EPS Growth 3Y | 75.31% | EPS Growth 5Y | 121.74% |
| Revenue Growth 1Y | 16.25% | Gross Margin | 0.75% |
| Operating Margin | 0.29% | Profit Margin | 0.28% |
| ROE | 0.13% | ROA | 0.1% |
| ROCE | 0.13% | Current Ratio | 4.74 |
| Quick Ratio | 4.74 | Cash Ratio | 1.11 |
| Debt/Equity | 0.01 | Interest Coverage | — |
| Altman Z Score | 15.27 | Piotroski Score | 5 |
Veeva Systems (VEEV) valuation & financials
Veeva Systems (VEEV) has a market capitalization of $39.60B and trades at a price-to-earnings ratio of 29.3. It operates in the Healthcare sector (Medical - Healthcare Information Services).
Veeva Systems's revenue grew +16.2% over the last year.
Veeva Systems's next earnings report is scheduled for September 2, 2026 after market close; analysts estimate EPS of $2.22. Check the earnings calendar to see all companies reporting this week.
Veeva Systems (VEEV) — frequently asked questions
When does Veeva Systems (VEEV) report earnings next?
Veeva Systems is expected to report earnings on September 2, 2026 after market close. Analysts estimate EPS of $2.22.
What is Veeva Systems's market cap?
Veeva Systems (VEEV) has a market capitalization of $39.60B.
What is VEEV's P/E ratio?
Veeva Systems trades at a price-to-earnings ratio of 29.3, with trailing twelve-month EPS of $8.33.
How fast is Veeva Systems growing?
Veeva Systems's revenue grew +16.2% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)